Kappa Psi Pharmaceutical Fraternity Fall Meeting_Treatment of Patients with Type 2 DM and CKD: Have Times Changed?
Date: Nov 2, 2020 08:00 PM - 09:30 PM
Fee
$0.00
CE Hours
1.50
CE Units
0.150
Registration closes on Dec 28, 2020 10:30 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Mon, Nov 02, 2020
Registration closes on Dec 28, 2020
at 10:30 PM
Mon, Nov 02, 2020
Registration closes on Dec 28, 2020
at 10:30 PM
Treatment of Patients with Type 2 Diabetess Mellitus and Chronic Kidney Disease: Have Times Changed?
Registration Closed
Treatment of Patients with Type 2 Diabetess Mellitus and Chronic Kidney Disease: Have Times Changed?
Registration Closed
Objectives
- Explain the importance of controlling diabetic kidney disease
- Outline treatment modalities for patients with Type 2 diabetes mellitus and chronic kidney disease (CKD)
- Identify the clinical trial findings that led to supporting the use of sodium glucose co-transporter-2 inhibitors (SGLT-2) in diabetic patients with chronic kidney disease
Speaker(s)/Author(s)
|
Dr. Christyn Mullen-Lee, PharmD, BCACP
|
Activity Number
0010-9999-20-051-L01-P
Date:
11/02/20
Time:
08:00 PM - 09:30 PM
CE Hours
1.50
Registration Closed